Generation Bio Co. – NASDAQ:GBIO

Add to watchlist

$6.34

+5.27

+492.52%

Market closed

Open in about 14 hours

-60.81%

month

-60.81%

quarter

-41.53%

year

Market Cap	79.81M
Enterprise value	262.40M

P/E	-1.87
EV/Sales	N/A
EV/EBITDA	-2.06
Price/Sales	N/A
Price/Book	0.96
PEG ratio	0.17
EPS	-2.55

Revenue	9.96M
EBITDA	-120.13M
Income	-169.05M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	-1205.84%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Generation Bio Co. (NASDAQ:GBIO): Profit margin
Jun 2023	880K	-31.06M	-3530.23%
Sep 2023	2.14M	-28.26M	-1317.15%
Dec 2023	2.87M	-35.18M	-1222.59%
Mar 2024	4.05M	-74.54M	-1836.44%

Generation Bio Financials Estimate

Q Y

Generation Bio Co. (NASDAQ:GBIO): Analyst Estimates
Sep 2025	650K	-24.44M	-3760.46%
Oct 2025	650K	-18.26M	-2810.65%
Dec 2025	650K	-18.26M	-2810.65%
Mar 2026	4.05M	-6.88M	-169.56%

Analysts Price target
Financials & Ratios estimates

Generation Bio Co. (NASDAQ:GBIO): Debt to assets
Jun 2023	404883000	150.59M	37.19%
Sep 2023	381492000	149.57M	39.21%
Dec 2023	374758000	171.63M	45.8%
Mar 2024	285879000	153.88M	53.83%

Generation Bio Co. (NASDAQ:GBIO): Cash Flow
Jun 2023	24.80M	24.41M	99K
Sep 2023	-24.89M	-26.58M	-131K
Dec 2023	-24.97M	-1.91M	77K
Mar 2024	-31.69M	-553K	-125K

Generation Bio alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Generation Bio Co. (NASDAQ:GBIO): Employee count
Aug 2023	150
Sep 2023	150
Oct 2023	150
Nov 2023	150
Dec 2023	150
Jan 2024	150
Feb 2024	150
Mar 2024	174
Apr 2024	174
May 2024	174
Jun 2024	174
Jul 2024	174

Generation Bio
Hedge Funds Holdings Q3 2022

97.40% +0.19%

of GBIO is owned by hedge funds

100 +8

hedge funds hold GBIO stock

55.66M +255.34K

shares is hold by hedge funds

GBIO hedge funds holdings changes

Generation Bio
Insider Trading

Generation Bio Co. (NASDAQ:GBIO): Insider trades (number of shares)
Period	Buy	Sel
Aug 2023	0	3116
Dec 2023	551455	0
Jan 2024	0	4890
Jul 2024	0	6719

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	1 Jul 2024	PAONE ANTOINETTE officer: CHIEF OPERATING OFFICER officer: CHIEF OPERATING OFFICER	Common Stock	6,719	$2.74	$18,410
Option	15 Apr 2024	STANTON MATTHEW officer: CHIEF SCIENTIFIC OFFICER officer: CHIEF SCIENTIFIC OFFICER	Common Stock	1,674	N/A	N/A
Option	15 Apr 2024	PAONE ANTOINETTE officer: CHIEF OPERATING OFFICER officer: CHIEF OPERATING OFFICER	Restricted Stock Units	1,592	N/A	N/A
Option	15 Apr 2024	STANTON MATTHEW officer: CHIEF SCIENTIFIC OFFICER officer: CHIEF SCIENTIFIC OFFICER	Restricted Stock Units	1,674	N/A	N/A
Option	15 Apr 2024	SAMAYOA PHILLIP officer: CHIEF STRATEGY OFFICER officer: CHIEF STRATEGY OFFICER	Common Stock	1,147	N/A	N/A
Option	15 Apr 2024	SAMAYOA PHILLIP officer: CHIEF STRATEGY OFFICER officer: CHIEF STRATEGY OFFICER	Restricted Stock Units	1,147	N/A	N/A
Option	15 Apr 2024	PAONE ANTOINETTE officer: CHIEF OPERATING OFFICER officer: CHIEF OPERATING OFFICER	Common Stock	1,592	N/A	N/A
Option	15 Apr 2024	NORKUNAS MATTHEW officer: CHIEF FINANCIAL OFFICER officer: CHIEF FINANCIAL OFFICER	Common Stock	1,673	N/A	N/A
Option	15 Apr 2024	NORKUNAS MATTHEW officer: CHIEF FINANCIAL OFFICER officer: CHIEF FINANCIAL OFFICER	Common Stock	1,674	N/A	N/A
Option	15 Apr 2024	NORKUNAS MATTHEW officer: CHIEF FINANCIAL OFFICER officer: CHIEF FINANCIAL OFFICER	Restricted Stock Units	1,674	N/A	N/A

GBIO insider trading transactions

Status	Patent	Filling date	Issue date
Application	Application LIPID NANOPARTICLE COMPOSITIONS COMPRISING CLOSED-ENDED DNA AND CLEAVABLE LIPIDS AND METHODS OF USE THEREOF Filling date: 3 Sep 2020 Issue date: 8 Sep 2022	3 Sep 2020	8 Sep 2022
Application	Application COMPOSITIONS AND PRODUCTION OF NICKED CLOSED-ENDED DNA VECTORS Filling date: 17 Jul 2020 Issue date: 21 Jul 2022	17 Jul 2020	21 Jul 2022
Application	Application SYNTHETIC PRODUCTION OF SINGLE-STRANDED ADENO ASSOCIATED VIRAL DNA VECTORS Filling date: 17 Jul 2020 Issue date: 14 Jul 2022	17 Jul 2020	14 Jul 2022
Application	Application CLOSED-ENDED DNA (CEDNA) AND IMMUNE MODULATING COMPOUNDS Filling date: 6 Mar 2020 Issue date: 16 Jun 2022	6 Mar 2020	16 Jun 2022
Application	Application NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING FVIII THERAPEUTICS Filling date: 13 Mar 2020 Issue date: 9 Jun 2022	13 Mar 2020	9 Jun 2022
Application	Application NON-ACTIVE LIPID NANOPARTICLES WITH NON-VIRAL, CAPSID FREE DNA Filling date: 6 Mar 2020 Issue date: 9 Jun 2022	6 Mar 2020	9 Jun 2022
Application	Application CONTROLLED EXPRESSION OF TRANSGENES USING CLOSED-ENDED DNA (CEDNA) VECTORS Filling date: 21 Feb 2019 Issue date: 9 Jun 2022	21 Feb 2019	9 Jun 2022
Application	Application MODULATION OF REP PROTEIN ACTIVITY IN CLOSED-ENDED DNA (CEDNA) PRODUCTION Filling date: 14 Feb 2020 Issue date: 28 Apr 2022	14 Feb 2020	28 Apr 2022
Application	Application CLOSED-ENDED DNA (CEDNA) AND USE IN METHODS OF REDUCING GENE OR NUCLEIC ACID THERAPY RELATED IMMUNE RESPONSE Filling date: 24 Jan 2020 Issue date: 21 Apr 2022	24 Jan 2020	21 Apr 2022
Application	Application NON-VIRAL DNA VECTORS AND USES THEREOF FOR ANTIBODY AND FUSION PROTEIN PRODUCTION Filling date: 14 Feb 2019 Issue date: 10 Feb 2022	14 Feb 2019	10 Feb 2022

Generation Bio
Executives

Insider	Age	Compensation
Dr. Cameron Geoffrey McDonough (1970) Pres, Chief Executive Officer, Sec. & Director	55	$856,880
Dr. Tracy Zimmermann Ph.D. (1970) Chief Devel. Officer	55	$507,920
Dr. Matthew Norkunas M.B.A., M.D. (1978) Chief Financial Officer	47	$357,650

Generation Bio
Latest News

Wednesday, 6 November 2024
18:45	Generation Bio Co. (GBIO) Reports Q3 Loss, Tops Revenue Estimates	zacks.com
Tuesday, 22 October 2024
06:59	Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress	globenewswire.com
Thursday, 12 September 2024
16:05	Generation Bio to Present at the 2024 Cantor Global Healthcare Conference	globenewswire.com
Wednesday, 7 August 2024
20:36	Generation Bio Co. (GBIO) Reports Q2 Loss, Tops Revenue Estimates	zacks.com
Tuesday, 6 August 2024
06:59	Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference	globenewswire.com
Friday, 14 June 2024
06:59	Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit	globenewswire.com
Monday, 13 May 2024
18:15	Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates	Zacks Investment Research
Wednesday, 6 March 2024
18:41	Generation Bio Co. (GBIO) Reports Q4 Loss, Lags Revenue Estimates	Zacks Investment Research
Tuesday, 27 February 2024
06:59	Generation Bio to Present at the 2024 TD Cowen Health Care Conference	GlobeNewsWire
Wednesday, 3 January 2024
16:05	Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference	GlobeNewsWire
Thursday, 7 December 2023
15:36	3 Penny Stocks To Buy According To Insiders In December	PennyStocks
Friday, 20 October 2023
08:15	Top 4 Health Care Stocks That May Rocket Higher This Month - Generation Bio (NASDAQ:GBIO), Evelo Biosciences (NASDAQ:EVLO)	Benzinga
Thursday, 3 August 2023
07:30	Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference	GlobeNewsWire
Wednesday, 31 May 2023
07:30	Generation Bio to Present at the 2023 Jefferies Healthcare Conference	GlobeNewsWire
Wednesday, 10 May 2023
19:45	Generation Bio Co. (GBIO) Reports Q1 Loss, Misses Revenue Estimates	Zacks Investment Research
Tuesday, 9 May 2023
16:15	Generation Bio to Present at the JMP Securities Life Sciences Conference	GlobeNewsWire
Tuesday, 11 April 2023
07:30	Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference	GlobeNewsWire
Friday, 24 March 2023
15:03	Best Penny Stocks To Buy Now? 10 To Watch Under $5	PennyStocks
Thursday, 23 March 2023
10:53	Penny Stocks To Buy Under $5? 7 To Watch This Week	PennyStocks
07:44	Generation Bio, Moderna announce collaboration	Market Watch
Monday, 27 February 2023
07:30	Generation Bio to Present at the 43rd Annual Cowen Healthcare Conference	GlobeNewsWire
Tuesday, 3 January 2023
16:30	Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference	GlobeNewsWire
Thursday, 22 September 2022
07:30	Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit	GlobeNewsWire
Thursday, 4 August 2022
18:48	Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates	Zacks Investment Research
Tuesday, 2 August 2022
16:15	Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference	GlobeNewsWire
Monday, 11 July 2022
11:36	Wall Street Analysts See a 174% Upside in Generation Bio Co. (GBIO): Can the Stock Really Move This High?	Zacks Investment Research
Thursday, 2 June 2022
07:30	Generation Bio to Present at the 2022 Jefferies Healthcare Conference	GlobeNewsWire
Wednesday, 5 January 2022
07:30	Generation Bio to Present at 40th Annual J.P. Morgan Healthcare Conference	GlobeNewsWire
Tuesday, 14 December 2021
12:46	Generation Bio Hits 52-Week Low After Preclinical Data From Hemophilia A Program	Benzinga
Thursday, 21 October 2021
16:05	Generation Bio to Present at Jefferies Virtual Gene Therapy/Editing Summit	GlobeNewsWire

Frequently Asked Questions (FAQ)

What's the price of Generation Bio stock today?

One share of Generation Bio stock can currently be purchased for approximately $6.34.
When is Generation Bio's next earnings date?

Unfortunately, Generation Bio's (GBIO) next earnings date is currently unknown.
Does Generation Bio pay dividends?

No, Generation Bio does not pay dividends.
How much money does Generation Bio make?

Generation Bio has a market capitalization of 79.81M.
What is Generation Bio's stock symbol?

Generation Bio Co. is traded on the NASDAQ under the ticker symbol "GBIO".
What is Generation Bio's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Generation Bio?

Shares of Generation Bio can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Generation Bio's key executives?
Generation Bio's management team includes the following people:
- Dr. Cameron Geoffrey McDonough Pres, Chief Executive Officer, Sec. & Director(age: 55, pay: $856,880)
- Dr. Tracy Zimmermann Ph.D. Chief Devel. Officer(age: 55, pay: $507,920)
- Dr. Matthew Norkunas M.B.A., M.D. Chief Financial Officer(age: 47, pay: $357,650)
How many employees does Generation Bio have?

As Jul 2024, Generation Bio employs 174 workers.
When Generation Bio went public?

Generation Bio Co. is publicly traded company for more then 5 years since IPO on 12 Jun 2020.
What is Generation Bio's official website?

The official website for Generation Bio is generationbio.com.
Where are Generation Bio's headquarters?

Generation Bio is headquartered at 301 Binney Street, Cambridge, MA.
How can i contact Generation Bio?

Generation Bio's mailing address is 301 Binney Street, Cambridge, MA and company can be reached via phone at +61 76557500.

Generation Bio Co.

generationbio.com

Exchange:

NASDAQ

Full time employees:

174

Industry:

Biotechnology

Sector:

Healthcare

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

+61 76557500

301 Binney Street
Cambridge, MA 02142

CIK: 0001733294
ISIN: US37148K1007
CUSIP: 37148K100